Modi Ventures β Full Portfolio
54 tracked investments Β· listed companies and verified rows first
Abingworth is a life-sciences investment firm that backs early-stage biopharma and biotech companies, providing capital and operational support to help them develop new therapeutics.
BiotechLondon, GB
Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.
AI & Machine LearningDigital HealthMedical DevicesOxford, GB
Michalis Papadakis(CEO)Alastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)
Cancer Focus Fund is an oncology-focused investment fund, established with The University of Texas MD Anderson Cancer Center, that finances early clinical-stage cancer therapies such as immunotherapies, cell therapies, precision medicine and radiotherapeutics.
BiotechHealthtech
Developing next-generation Ξ³Ξ΄ T cell engagers as cancer therapies.
Cytospire Therapeutics develops multispecific antibodies and next-generation Ξ³Ξ΄ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Draper is a venture capital firm that invests in startups across AI and robotics, Bitcoin and blockchain, precision medicine and longevity, aerospace and space infrastructure, and frontier deeptech.
AI & Machine LearningCrypto & Web3Deep Tech
Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes.
Digital HealthHealthtechMedical Devices
Mark Emberton(Chief Medical Officer)
Evidence-based longevity intelligence platform for healthcare systems.
Developing therapy for neuropsychiatric symptoms of dementia, including agitation/aggression in Alzheimer's.
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Developing next-generation protein sequencing platform to redefine proteomics.
Glyphic Biotechnologies develops ProSEβ’, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Jimmy Yun(Director)
BoardCraig Asher(Director)
Groq designs and manufactures the LPU (Language Processing Unit), a chip purpose-built for AI inference, and operates GroqCloud, a platform for running inference workloads with low latency and cost efficiency across global data centers.
AI & Machine LearningCloud ComputingSemiconductors
Jonathan Ross(Founder & CEO)in
HealthTech Arkansas (HTA) helps medtech and healthtech companies from around the world enter the U.S. healthcare market by guiding U.S. strategy, arranging guaranteed hospital pilot projects and clinical trials through its coalition of clinical partners, and connecting them with U.S. investors.
Digital HealthHealthtechMedical Devices
Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases.
BiotechDeep TechHealthtechAustin, US
Matthew Porteus(Executive Officer, Director)Valentin Barsan(Executive Officer, Director)
BoardRaymond Kelleher(Director)Ness Bermingham(Director)
KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies.
BiotechDeep Tech
Jennifer Manning(Founder & CEO)Thomas Page(Acting CTO)Matt Farabaugh(Acting CFO)Jesse B. Owens(Acting CSA)Ray Tabibiazar(Chairman of the Board)
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)Charity Scripture(Executive Officer)Eric Soller(Executive Officer)
PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Raj Singh(Founder)Rajendra Singh(Co-founder)Cory Batenchuk(Senior Vice President, Operations & Co-founder)KV Acharya(System Architect & Co-founder)Patrick Myles(Chief Executive Officer)
ProFound Therapeutics identifies previously undiscovered proteins encoded by the human genome and characterizes their biological functions to find new drug targets and therapeutic proteins.
BiotechDeep Tech
Discovers and develops medicines targeting pathologic cells that drive aging.
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Samsara Capital is an investment firm that backs the development of therapeutics for patients.
Biotech
Serif Biomedicines develops technology to write DNA in different forms so that DNA can be used as a medicine, aiming to create a new category of genetic medicines to treat and prevent disease.
BiotechDeep Tech
Diagnostics, labs, and digital health platform for accessible detection and care at enterprise scale.
T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.
BiotechDigital HealthMedical Devices
Kwesi Frimpong-Boateng(Co-founder & Managing Partner)Michael Langer(Co-founder & Managing Partner)Corey M. McCann(Co-founder & Managing Partner)Robert Langer(Executive Chairman & Chair of Scientific Advisory Board)
Combines in-person clinic and online care for pet health.
Tandem is a veterinary clinic providing wellness exams, vaccines, preventive care, urgent care, and specialty services for cats and dogs, operating a full-service clinic in Somerville plus mobile and telehealth services.
ConsumerHealthtechSomerville, US
Techion develops FECPAK, a portable digital microscope and data platform that provides digital diagnosis and data management for animal, human, and environmental health, serving farmers and animal health specialists.
AgTechAI & Machine LearningData & InfrastructureDigital HealthMedical Devices
Greg Mirams(Founder and Managing Director)
Tiny Health provides microbiome testing kits and personalized health reports for families from pregnancy through adulthood, focusing on gut health optimization to address conditions like eczema, allergies, IBS, and constipation.
Digital HealthHealthtechWellness & Fitness
Yosemite is working toward making cancer non-lethal, focusing on cancer research and treatment.
BiotechLongevitySan Francisco, US
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.